| Original language | English (US) |
|---|---|
| Pages (from-to) | 23 |
| Number of pages | 1 |
| Journal | Oncology Report |
| Issue number | FALL |
| State | Published - Sep 2008 |
ASJC Scopus subject areas
- Hematology
- Oncology
AVADO: Bevacizumab/docetaxel provides small benefit in PFS. Commentary
Research output: Contribution to journal › Article › peer-review